Torrent Pharma Receives SEC Approval to Market Alogliptin-Metformin FDC, Asked to Conduct Phase IV Trial Susmita Roy23 Oct 2025 1:44 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted approval to...
Why Women Face Higher Risk of Alzheimer's and Multiple Sclerosis: Study Dr. Bhumika Maikhuri21 Oct 2025 8:15 AM ISTA recent study published in Science Translational Medicine, has identified a gene on the X chromosome that drives inflammation in the female brain...
CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis Susmita Roy20 Oct 2025 5:44 PM ISTNew Delhi: Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the Subject Expert...
Tirzepatide proves to be more effective than semaglutide- Results of Surmount 5 Trial Deeksha Bhandari3 Oct 2025 12:09 PM ISTSURMOUNT-5 was a 72-week, Phase 3b, multicenter, randomized, open-label, comparator-controlled study that evaluated the efficacy and safety of...
Real-World Case Insight: Triple FDC Therapy in a Young Diabetes Patient - Dr Naresh Kumar Deeksha Bhandari1 Oct 2025 12:50 PM ISTIn this video, Dr. Naresh Kumar, Consultant Diabetologist from Tamil Nadu, presents a real-world case of a 24-year-old male student with fatigue and...
NPPA Fixes Retail Prices of 9 Formulations Including Dapagliflozin, Sitagliptin, Aceclofenac FDCs, Details Susmita Roy16 Sept 2025 2:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC Susmita Roy15 Sept 2025 1:14 PM ISTNew Delhi: Eris Lifesciences has got the go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Fixed Dose Combination of Metformin-Voglibose Now CDSCO Approved Susmita Roy13 Sept 2025 6:20 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has clarified that the fixed-dose combination (FDC) of Voglibose 0.2 mg and...
Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study Deeksha Bhandari8 Sept 2025 12:00 PM ISTA real-world Indian study found that glipizide, alone or with metformin, improves glycemic control in patients with declining renal function without...
Sun Pharma Fails to Secure CDSCO Nod for BE, Phase III Waiver on Sitagliptin, Glimepiride, Metformin FDC Susmita Roy7 Sept 2025 3:30 PM ISTNew Delhi: Citing the absence of supporting data for the proposed strength of the fixed-dose combination (FDC) of Sitagliptin phosphate monohydrate,...
CDSCO Panel Rejects Theon Pharma's Proposal for Empagliflozin, Linagliptin, Metformin FDC Susmita Roy6 Sept 2025 2:34 PM ISTNew Delhi: Raising doubts over the rationality of the fixed-dose combination (FDC) in the proposed strength and its significant benefits, the Subject...
Early Metformin Use Lowers Long COVID Risk, Finds Study Medha Baranwal6 Sept 2025 8:45 AM ISTUK: A large UK target trial emulation using COVID-OUT trial data found that early use of metformin reduced the risk of long COVID by 36% at 1 year...
